IL22 and inflammatory bowel disease: Therefore, together with other AhR ligand candidates, including FICZ (114) and ABX464 (115), tryptophan and indigo naturalis might be promising therapeutic strategies in IBD patients by activating endogenous IL-22 production from intestinal ILC3s in order to protect and restore the intestinal epithelium.